Bispecific soluble cytokine receptor-nanobody fusions inhibit Interleukin (IL-)6 trans-signaling and IL-12/23 or tumor necrosis factor (TNF) signalingAnnika Gesiorowski, Jürgen Scheller|Journal of Biological Chemistry|2023Cited by 17